<DOC>
	<DOCNO>NCT01820520</DOCNO>
	<brief_summary>Study design evaluate safety efficacy double stain brilliant blue G 0.025 % adjuvant macular surgery . Patients undergo surgery macular hole epiretinal membrane include . Safety evaluate optic coherence tomography , pattern reversal electroretinogram multifocal electroretinogram .</brief_summary>
	<brief_title>Safety Efficacy Double Staining With Brilliant Blue G Macular Surgery</brief_title>
	<detailed_description />
	<mesh_term>Retinal Perforations</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<criteria>Patient age 18 year old Signing inform consent Macular pathology require vitrectomy ( epiretinal membrane , macular hole , vitreomacular traction syndrome ) Diagnosis glaucoma Known allergy brilliant blue G</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>